Share Email Print

Proceedings Paper

Combination therapy of potential gene to enhance oral cancer therapeutic effect
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The epidermal growth factor receptor (EGFR) over-regulation related to uncontrolled cell division and promotes progression in tumor. Over-expression of human epidermal growth factor receptor (EGFR) has been detected in oral cancer cells. EGFR-targeting agents are potential therapeutic modalities for treating oral cancer based on our in vitro study. Liposome nanotechnology is used to encapsulate siRNA and were modified with target ligand to receptors on the surface of tumor cells. We used EGFR siRNA to treat oral cancer in vitro.

Paper Details

Date Published: 9 March 2015
PDF: 3 pages
Proc. SPIE 9324, Biophotonics and Immune Responses X, 932417 (9 March 2015); doi: 10.1117/12.2081129
Show Author Affiliations
Chia-Hsien Yeh, Chung Yuan Christian Univ. (Taiwan)
Yih-Chih Hsu, Chung Yuan Christian Univ. (Taiwan)

Published in SPIE Proceedings Vol. 9324:
Biophotonics and Immune Responses X
Wei R. Chen, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?